Clinical trial design stories

Alpha-lipoic acid shows early promise for progressive MS in first positive neurological MAMS trial

A multi-arm, multi-stage trial has reported positive results for alpha-lipoic acid in treating progressive multiple sclerosis, marking the first time this innovative trial design has succeeded in a neurological condition. Diabetes drug metformin was removed from the trial, though the design allows additional drugs to be tested.